Evolution of Drug-resistant Acinetobacter baumannii After DCD Renal Transplantation
Hong Jiang1,2,3,4, Luxi Cao1,2,3,4, Lihui Qu1,2,3,4
1Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, P. R. China.
Abstract:
Infection after renal transplantation remains a major cause of morbidity and death, especially infection from the extensively drug-resistant bacteria, A. baumannii. A total of fourteen A. baumannii isolates were isolated from the donors' preserved fluid from DCD (donation after cardiac death) renal transplantation and four isolates in the recipients' draining liquid at the Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, from March 2013 to November 2014. An outbreak of A. baumannii emerging after DCD renal transplantation was tracked to understand the transmission of the pathogen. PFGE displayed similar DNA patterns between isolates from the same hospital. Antimicrobial susceptibility tests against thirteen antimicrobial agents were determined using the K-B diffusion method and eTest. Whole-genome sequencing was applied to investigate the genetic relationship of the isolates. With the clinical data and research results, we concluded that the A. baumannii isolates 3R1 and 3R2 was probably transmitted from the donor who acquired the bacteria during his stay in the ICU, while isolate 4R1 was transmitted from 3R1 and 3R2 via medical manipulation. This study demonstrated the value of integration of clinical profiles with molecular methods in outbreak investigation and their importance in controlling infection and preventing serious complications after DCD transplantation.
Insights
This study tracked an outbreak of extensively drug-resistant Acinetobacter baumannii infections following kidney transplants. Molecular methods identified transmission from donor to recipient and between patients, highlighting infection control importance.
Area of Science:
- Infectious Diseases
- Transplantation Immunology
- Microbiology
Background:
- Infection post-renal transplantation poses significant risks, particularly from multidrug-resistant organisms.
- Acinetobacter baumannii is a major threat in transplant recipients, leading to high morbidity and mortality.
- Donation after cardiac death (DCD) transplants may carry unique infectious risks.
Purpose of the Study:
- To investigate an outbreak of Acinetobacter baumannii infections in DCD renal transplant recipients.
- To determine the transmission routes of Acinetobacter baumannii in a transplant setting.
- To evaluate the utility of integrated clinical and molecular methods for outbreak investigation.
Main Methods:
- Isolation and identification of Acinetobacter baumannii from donor preserved fluid and recipient draining fluid.
- Pulsed-field gel electrophoresis (PFGE) for initial DNA fingerprinting.
- Antimicrobial susceptibility testing (K-B diffusion and eTest).
- Whole-genome sequencing for detailed genetic analysis and phylogenetic relationships.
Main Results:
- Fourteen Acinetobacter baumannii isolates were recovered from DCD donor fluid and four from recipient draining fluid.
- PFGE indicated similar DNA patterns among isolates from the same hospital.
- Whole-genome sequencing confirmed transmission events, implicating donor-to-recipient spread and nosocomial transmission via medical procedures.
- Isolates 3R1 and 3R2 likely originated from the donor, while 4R1 was transmitted through medical manipulation.
Conclusions:
- Acinetobacter baumannii can be transmitted from DCD donors to recipients, posing a serious threat.
- Nosocomial transmission through medical interventions is a significant risk factor in transplant-associated outbreaks.
- Combining clinical data with molecular techniques is crucial for effective outbreak investigation and infection control in transplantation.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

